Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
+4.02M
-
Total reported value, excl. options
-
$103M
-
Value change
-
+$30.1M
-
Put/Call ratio
-
0.36
-
Number of buys
-
34
-
Number of sells
-
-10
-
Price
-
$7.51
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q4 2024
58 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q4 2024.
Profound Medical Corp. - Common Shares (PROF) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 29.9M outstanding shares and own 46.06% of the company stock.
Largest 10 shareholders include FIL Ltd (1.8M shares), GAGNON SECURITIES LLC (1.65M shares), LETKO, BROSSEAU & ASSOCIATES INC (1.21M shares), Timelo Investment Management Inc. (912K shares), Gagnon Advisors, LLC (897K shares), RAYMOND JAMES FINANCIAL INC (876K shares), ROYCE & ASSOCIATES LP (765K shares), Rosalind Advisors, Inc. (692K shares), Magnetar Financial LLC (509K shares), and MMCAP International Inc. SPC (490K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.